SCHWAB; Wilfried

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHWAB; Wilfried.The latest application filed is for "maleate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridiny- l)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof".

Company Profile

5.35.32

SCHWAB; Wilfried - Werder DE
Schwab; Wilfried - Velbert DE
Schwab; Wilfried - Marktheidenfeld DE
Schwab; Wilfried - Wuppertal N/A DE
SCHWAB; Wilfried - Werder Havel
Schwab; Wilfried - Neuried DE
Schwab; Wilfried - Wiesbaden-Naurod DE
Schwab; Wilfried - Wiesbaden DE
Schwab; Wilfried - Kelkheim DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Maleate Salt Of The Free Base Of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridiny- L)-phenyl]-acetamide, Pharmaceutical Formulations, Methods Of Manufacture And Uses Thereof App 20220152009 - BACHHAV; Yogeshwar ; et al.	2022-05-19
Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridiny- l)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes viruses Grant 11,266,636 - Bachhav , et al. March 8, 2	2022-03-08
N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl- )-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof App 20210269429 - BACHHAV; Yogeshwar ; et al.	2021-09-02
N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl- )-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof Grant 11,021,474 - Bachhav , et al. June 1, 2	2021-06-01
A Maleate Salt Of The Free Base Of N-[5-(aminosulfonyl)-4-methyl-1.3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridiny- L)-phenyl]-acetamide, Pharmaceutical Formulations, Methods Of Manufacture And Uses Thereof For The Treatment Of Herpes Viruses App 20200289485 - BACHHAV; Yogeshwar ; et al.	2020-09-17
N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl- )-phenyl]-acetamide free base hemihydrate, methods o App 20200123145 - BACHHAV; Yogeshwar ; et al.	2020-04-23
Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative Grant 10,603,384 - Paulus , et al.	2020-03-31
Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration Grant 10,442,773 - Schwab , et al. Oc	2019-10-15
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl- )phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Grant 10,137,117 - Schwab , et al. November 27, 2	2018-11-27
Glycosylated Aroma- And Fragrance Precursors And Fragrance Products That Can Be Activated App 20180127681 - Schwab; Wilfried ; et al.	2018-05-10
Process for making substituted quinazoline compounds Grant 9,890,128 - Luzung , et al. February 13, 2	2018-02-13
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridiny- l)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Grant 9,889,124 - Schwab , et al. February 13, 2	2018-02-13
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n- Methyl-2-[4-(2-pyridinyl)phenyl]acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations App 20170348297 - SCHWAB; Wilfried ; et al.	2017-12-07
Glycosyl Transferases And Their Uses App 20170204380 - SCHWAB; Wilfried	2017-07-20
Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents Grant 9,637,459 - Grunenberg , et al. May 2, 2	2017-05-02
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridiny- l)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Grant 9,592,225 - Schwab , et al. March 14, 2	2017-03-14
Process For Making Substituted Quinazoline Compounds App 20160311781 - Luzung; Michael ; et al.	2016-10-27
Amorphous Letermovir And Solid Pharmaceutical Formulations Thereof For Oral Administration App 20160145216 - SCHWAB; Wilfried ; et al.	2016-05-26
N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl- )phenyl]acetamide mesylate monohydrate Grant 9,340,535 - Schwab , et al. May 17, 2	2016-05-17
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridiny- L)phenyl]acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations App 20160008341 - SCHWAB; Wilfried ; et al.	2016-01-14
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridiny- L)phenyl]acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations App 20150366849 - SCHWAB; Wilfried ; et al.	2015-12-24
Sulfonic acid salts of heterocyclylamide-substituted imidazoles Grant 9,133,165 - Schwab , et al. September 15, 2	2015-09-15
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridiny- l)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Grant 9,119,786 - Schwab , et al. September 1, 2	2015-09-01
Pharmaceutical Composition Containing An Antivirally Active Dihydroquinazoline Derivative App 20150133461 - Paulus; Kerstin ; et al.	2015-05-14
Sodium And Calcium Salts Of Dihydroquinazoline Derivative And Use Thereof As Antiviral Agents App 20150038514 - Grunenberg; Alfons ; et al.	2015-02-05
Sulfonic Acid Salts Of Heterocyclylamide-substituted Imidazoles App 20140315924 - Schwab; Wilfried ; et al.	2014-10-23
N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl- )phenyl]acetamide mesylate monohydrate App 20140221433 - Schwab; Wilfried ; et al.	2014-08-07
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridiny- L)phenyl]acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations App 20140065224 - SCHWAB; Wilfried ; et al.	2014-03-06
4,6-disubstituted Aminopyrimidine Derivatives As Inhibitors Of Protein Kinases App 20130338147 - Wabnitz; Philipp ; et al.	2013-12-19
4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases Grant 8,507,498 - Wabnitz , et al. August 13, 2	2013-08-13
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases Grant 8,084,457 - Choidas , et al. December 27, 2	2011-12-27
4, 6-disubstituted Aminopyrimidine Derivatives As Inhibitors Of Protein Kinases App 20110306602 - Wabnitz; Philipp ; et al.	2011-12-15
Pyridinylamines App 20090196912 - Eickhoff; Jan Elke ; et al.	2009-08-06
Napthyridine Compounds As Rock Inhibitors App 20080207677 - Muller; Stefan ; et al.	2008-08-28
Pyrazine Derivatives As Effective Compounds Against Infectious Diseases App 20080194574 - Eikhoff; Jan Eike ; et al.	2008-08-14
Technically Produced Dihydrocoumarin App 20080171123 - Wenk; Hans Henning ; et al.	2008-07-17
Heterobicyclic Compounds as Pharmaceutically Active Agents App 20070275962 - Koul; Anil ; et al.	2007-11-29
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases App 20070191344 - Choidas; Axel ; et al.	2007-08-16
Optically active .beta.-aminoketones, optically active 1,3-amino alcohols and processes for preparing them Grant 7,161,008 - Jendralla , et al. January 9, 2	2007-01-09
Sulfonylaminocarboxylic acids Grant 7,160,903 - Thorwart , et al. January 9, 2	2007-01-09
Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides Grant 6,894,184 - Hachtel , et al. May 17, 2	2005-05-17
Cyclic and heterocyclic N-substituted .alpha.-iminohydroxamic and -carboxylic acids Grant 6,815,440 - Thorwart , et al. November 9, 2	2004-11-09
Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides App 20040186173 - Hachtel, Jochen ; et al.	2004-09-23
Optically active B-aminoketones, optically active 1,3-amino alcohols and processes for preparing them App 20040030145 - Jendralla, Heiner ; et al.	2004-02-12
Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids App 20030176432 - Thorwart, Werner ; et al.	2003-09-18
Sulfonylaminocarboxylic acids App 20030087945 - Thorwart, Werner ; et al.	2003-05-08
Sulfonylaminocarboxylic acids Grant 6,451,824 - Thorwart , et al. September 17, 2	2002-09-17
Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and use App 20020082246 - Schudok, Manfred ; et al.	2002-06-27
N-arylsulfonylamino acid omega-amides Grant 6,335,333 - Schwab , et al. January 1, 2	2002-01-01
Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids App 20010011134 - Thorwart, Werner ; et al.	2001-08-02
Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use Grant 6,235,727 - Schudok , et al. May 22, 2	2001-05-22
Cyclic and heterocyclic N-substituted .alpha.-iminohydroxamic and carboxyclic acids Grant 6,207,672 - Thorwart , et al. March 27, 2	2001-03-27
Substituted diaminocarboxylic acids Grant 6,159,995 - Thorwart , et al. December 12, 2	2000-12-12
2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives Grant 6,121,316 - Schwab , et al. September 19, 2	2000-09-19
Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders Grant 5,886,033 - Schwab , et al. March 23, 1	1999-03-23
3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and isoxazoles, process for their preparation and their use as pharmaceuticals Grant 5,814,627 - Schwab , et al. September 29, 1	1998-09-29
Isoxazolines, their preparation, and their use as plant-protecting agents Grant 5,314,863 - Loher , et al. May 24, 1	1994-05-24
2-cyano-3-hydroxy-enamides Grant 5,308,865 - Bartlett , et al. May 3, 1	1994-05-03
3,5-disubstituted 2-isoxazolines and isoxazoles, agents containing them and their use Grant 5,273,989 - Schwab , et al. December 28, 1	1993-12-28
Process for the manufacture of 3-pyridinium-methyl-cephalosporins Grant 4,692,516 - Kirrstetter , et al. * September 8, 1	1987-09-08
Process for the preparation of cephem compounds Grant 4,667,028 - Schwab , et al. May 19, 1	1987-05-19
Cephalosporin derivatives Grant 4,647,556 - Lattrell , et al. March 3, 1	1987-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.